Ronald Seth Van Dyke, FNP-C

Ronald Van Dyke practices at Harbin Clinic Gastroenterology Endoscopy & GI Lab Rome in Rome, Georgia.

Ronald Van Dyke's NPI, 1013543990, was assigned on March 23, 2020. Ronald Van Dyke holds Georgia license RN258955.

Ronald Van Dyke's primary practice is Harbin Clinic Gastroenterology Endoscopy & GI Lab Rome, at 1825 Martha Berry Blvd., Rome, GA 30165. The practice phone is (706) 238-8010.

Ronald Van Dyke's primary practice is Harbin Clinic Gastroenterology Endoscopy & GI Lab Rome in Rome, Georgia. Ronald Van Dyke is also affiliated with Atrium Health Floyd Medical Center. The medical group on file is Harbin Clinic. Dmand AI also links Ronald Van Dyke to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ronald Van Dyke practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Ronald Van Dyke's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Ronald Van Dyke is licensed in Georgia.

CMS counts 330 Medicare patients who saw Ronald Van Dyke in 2024. The largest group is 75 to 84, with 137 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ronald Van Dyke's median patient age at 75, with 54% women.

In 2024, Ronald Van Dyke wrote 311 Medicare Part D claims for 109 patients. 90% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Ronald Van Dyke for performance year 2024, reported as part of a group. Ronald Van Dyke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ronald Van Dyke as offering telehealth.

CMS Open Payments shows 1 general payment to Ronald Van Dyke from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Ardelyx, Inc. paid the most, $124.